Truebinding, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.truebinding.com
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- TrueBinding, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT06773962
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸Central Texas Neurology Consultants, Round Rock, Texas, United States
🇺🇸Parkinson's Research Centers of America - Orange County, Aliso Viejo, California, United States
TB006 Expanded Access (EA) Compassionate Use
- Conditions
- Alzheimer Disease
- First Posted Date
- 2023-07-25
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- TrueBinding, Inc.
- Registration Number
- NCT05959239
A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- TrueBinding, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT05476783
- Locations
- 🇺🇸
Clinical Trial Site, Fairfax, Virginia, United States
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stroke
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- TrueBinding, Inc.
- Registration Number
- NCT05156827
Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
- First Posted Date
- 2021-10-12
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- TrueBinding, Inc.
- Target Recruit Count
- 154
- Registration Number
- NCT05074498
- Locations
- 🇺🇸
Clinical Trial Site, Fairfax, Virginia, United States
🇺🇸Clinical Trial Site #1, Maitland, Florida, United States
Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy Subjects
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- TrueBinding, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04920786
- Locations
- 🇺🇸
Collaborative Neuroscience Research, LLC (CNS), Long Beach, California, United States
Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- TrueBinding, Inc.
- Registration Number
- NCT04801056
© Copyright 2025. All Rights Reserved by MedPath